---
title: "Samuel Murray — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e51495fa-d2cc-55aa-a021-6d09f2de0df9
json: https://whiteintel.dev/api/public/dossier/e51495fa-d2cc-55aa-a021-6d09f2de0df9
identifier: oo-person:GB-COH-PER-15054168-y24uMLB5HFmyXY3JnV4MBcVO0zc
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Samuel Murray

**Type:** Person  
**Jurisdiction:** GB  
**Identifier:** `oo-person:GB-COH-PER-15054168-y24uMLB5HFmyXY3JnV4MBcVO0zc`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e51495fa-d2cc-55aa-a021-6d09f2de0df9  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e51495fa-d2cc-55aa-a021-6d09f2de0df9  

## Ownership & control

### Holdings / subsidiaries

- **MOZAIC BIOPHARMA LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/dfd86030-e035-5a50-b258-db03cfad97eb

## Provenance

- OpenOwnership — https://www.openownership.org

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Samuel Murray**. Human view: https://whiteintel.dev/entity/e51495fa-d2cc-55aa-a021-6d09f2de0df9 · Structured JSON: https://whiteintel.dev/api/public/dossier/e51495fa-d2cc-55aa-a021-6d09f2de0df9._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._